Mr. Daniel Cohen reports
AURA ENTERS PR CAMPAIGN IN WESTERN CANADA & GRANTS OPTIONS TO DIRECTOR
Aura Health Inc. has entered into a strategic public relations campaign in Western Canada with R. Ian Cochrane. Mr. Cochrane brings three decades of marketing small and microcap companies in Western Canada. He will be an important asset in increasing the wherewithal of Aura in the western provinces.
Aura will compensate Mr. Cochrane by granting 350,000 stock options of the company on Jan. 17, 2019, exercisable at 24.5 cents. Two hundred thousand options shall vest immediately with 150,000 options to vest on April 17, 2019. The options shall expire on Jan. 17, 2021.
The company is also pleased to announce the grant of 200,000 options to Joel Freudman, Aura's independent director and chair of the board of directors' audit committee, on Jan. 17, 2019. Since entering into the role in October, 2018, Mr. Freudman has played an important role in guiding the company in audit and finance related issues. The options shall be exercisable at 23.5 cents, will vest immediately and expire on Jan. 17, 2021.
About Aura Health Inc.
Aura Health is building an international network of vertically integrated cannabis assets. Through an established product line of cannabis-infused edible products and oil extracts, Aura is dedicated to building a high-margin downstream business in the medical marijuana sector. The company holds convertible debt that converts to 54-per-cent equity of HolyCanna, a cultivation and nursery licence holder in Israel. The company also owns a 30-per-cent interest in four medical marijuana clinics in the U.S. Sun Belt.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.